Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
CNBX Pharmaceuticals Inc. (CNBX)
Standardized SEC financial data for CNBX Pharmaceuticals Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001343009 · OTC · Pharmaceutical Preparations.
Revenue growth (YoY)
-100.0%
Return on equity
12.6%
Free cash flow
-$171K
Current ratio
0.01×
EPS (diluted)
$0.00
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
USD
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
$7K
$0
$30K
$410K
$130K
$0
R&D expense
$1.7M
$1.8M
$1.2M
$432K
$195K
$0
SG&A expense
$1.3M
$829K
$1.8M
$910K
$518K
$272K
Operating income
-$3.0M
-$2.6M
Standardized from CNBX Pharmaceuticals Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.